Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant β‐interferon and hyperfractionated radiation therapy: A Childrens Cancer Group phase I/II study

Prognosis for the majority of children with brain stem gliomas is dismal. In previous studies, recombinant beta‐interferon (rβIF) has been shown to be effective for children with recurrent brain stem gliomas and may also act synergistically with radiotherapy (RT).

[1]  R. Zimmerman,et al.  Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A childrens cancer group phase 1/11 trial , 1994, Cancer.

[2]  R. Zimmerman,et al.  Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas A childrens cancer group phase I/II trial , 1993, Cancer.

[3]  M. Prados,et al.  Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults. , 1992, International journal of radiation oncology, biology, physics.

[4]  W. Yung,et al.  Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Krischer,et al.  Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cgy dose level of pediatric oncology group study #8495 , 1991, Cancer.

[6]  R. Packer,et al.  Dilemmas in the management of childhood brain tumors: brainstem gliomas. , 1991, Pediatric neurosurgery.

[7]  M. Prados,et al.  Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Packer,et al.  Biologic and immune modulating agents in the treatment of childhood brain tumors. , 1991, Neurologic clinics.

[9]  J. Krischer,et al.  Brain stem gliomas: a classification system based on magnetic resonance imaging. , 1990, Pediatric neurosurgery.

[10]  R. Zimmerman,et al.  Hyperfractionated radiotherapy for children with brainstem gliomas: A pilot study using 7,200 cGy , 1990, Annals of neurology.

[11]  Michael S. B. Edwards,et al.  Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. , 1989, Journal of neurosurgery.

[12]  P. Keng,et al.  Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. , 1987, Cancer research.

[13]  R. Whaley,et al.  Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas. , 1985, Journal of neurosurgery.

[14]  E. Borden,et al.  Radiosensitization of human bronchogenic carcinoma cells by interferon beta. , 1984, Journal of interferon research.

[15]  G. Gillespie,et al.  Immunologic Considerations of Patients with Brain Tumors , 1983 .

[16]  M. Nagai,et al.  [Interferon therapy for malignant brain tumors-present and future (author's transl)]. , 1982, No shinkei geka. Neurological surgery.

[17]  Robert E. Gentry,et al.  Immunobiology of primary intracranial tumors. , 1977, Journal of neurosurgery.

[18]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[19]  J. Moore,et al.  Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases. , 1976, British Journal of Cancer.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .